These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 6506048)

  • 41. [Peritoneovenous shunt in the treatment of intractable ascites in cirrhotic patients. UCL experience].
    Gigot JF; Gianello P; Verhelst R; Reynaert M; Otte JB; Kestens PJ
    Acta Gastroenterol Belg; 1986; 49(1):33-49. PubMed ID: 3766059
    [No Abstract]   [Full Text] [Related]  

  • 42. [Leveen peritoneovenous shunt in refractory ascites].
    Berr F; Engelhardt D; Paulus W; Rindfleisch GE; Witte J
    Internist (Berl); 1983 Jan; 24(1):59-63. PubMed ID: 6341282
    [No Abstract]   [Full Text] [Related]  

  • 43. [Comparative evaluation of the effects of a peritoneo-venous shunt and of concentration-reinfusion on the survival of cirrhotic subjects with "intractable" ascites].
    Torre GC; Testa R
    Minerva Med; 1982 Jun; 73(27):1871-5. PubMed ID: 7088400
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Retransfusion of ascites fluid in cirrhotic patients, using external peritoneovenous and peritoneopulmonary shunts (personal technic)].
    Mircea N; Constantinescu C; Jianu E; Constantinescu N
    Rev Chir Oncol Radiol O R L Oftalmol Stomatol Chir; 1984; 33(1):45-54. PubMed ID: 6233645
    [No Abstract]   [Full Text] [Related]  

  • 45. [Long-term results of the peritoneovenous shunt in the treatment of intractable ascites in cirrhotic patients].
    Dellepiane M; Capussotti L; Polastri R; Mensa G; Marucci MM; Fusario F
    Minerva Med; 1987 May; 78(10):717-20. PubMed ID: 3587721
    [No Abstract]   [Full Text] [Related]  

  • 46. Palliation of malignant ascites by the Denver peritoneovenous shunt.
    Downing R; Black J; Windsor CW
    Ann R Coll Surg Engl; 1984 Sep; 66(5):340-3. PubMed ID: 6207757
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Application of a membraneous peritoneovenous shunting device].
    Li HC
    Zhonghua Wai Ke Za Zhi; 1983 Mar; 21(3):152-5. PubMed ID: 6872751
    [No Abstract]   [Full Text] [Related]  

  • 48. [Bleeding complications of the LeVeen shunt].
    Friedrichs O
    Med Welt; 1983 Jul; 34(27):754-5. PubMed ID: 6888245
    [No Abstract]   [Full Text] [Related]  

  • 49. Chylous ascites: resolution after Denver peritoneovenous shunt.
    Turner WW
    South Med J; 1983 Apr; 76(4):539. PubMed ID: 6601302
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Peritoneovenous shunt in treatment of ascites in patients with cirrhosis. A preliminary report with special reference to pathophysiology.
    Henriksen JH; Malchow-Møller A; Ring-Larsen H; Jensen JL; Dietrichson O; Staehr-Johansen T; Juhl E
    Scand J Gastroenterol; 1983 May; 18(4):529-35. PubMed ID: 6669928
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Treatment of intractable ascites in cirrhotic patients by portal shunt].
    Franco D
    Gastroenterol Clin Biol; 1983 May; 7(5):533-9. PubMed ID: 6873567
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Peritoneovenous shunt in the management of ascites and the hepatorenal syndrome.
    Epstein M
    Gastroenterology; 1982 Apr; 82(4):790-9. PubMed ID: 7037522
    [No Abstract]   [Full Text] [Related]  

  • 53. [Peritovenous shunt (Denver Shunt) in therapy resistant ascites in childhood].
    Teufel M; Reifferscheid P; Niessen KH
    Monatsschr Kinderheilkd; 1983 Sep; 131(9):603-6. PubMed ID: 6621573
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Complications of peritoneovenous shunting for malignant ascites. A collective review.
    Vo NM; Tortora MJ; DeMaio JT; Aseltine DT
    Conn Med; 1981 Jan; 45(1):1-4. PubMed ID: 7226782
    [No Abstract]   [Full Text] [Related]  

  • 55. [Peritoneovenous shunt in the treatment of refractory ascites].
    Sehnert W; Hackenberg K; Bussmann JF
    Med Welt; 1984 Jan; 35(4):120-4. PubMed ID: 6700423
    [No Abstract]   [Full Text] [Related]  

  • 56. [Peritoneovenous shunt in the treatment of persistent ascites in patients with portal hypertension].
    Patsiora MD; Lebezev VM
    Klin Med (Mosk); 1983 May; 61(5):66-8. PubMed ID: 6876704
    [No Abstract]   [Full Text] [Related]  

  • 57. Strategies for intractable ascites after hepatic resection: analysis of two cases.
    Maeda T; Shimada M; Shirabe K; Taketomi A; Matsumata T; Sugimachi K
    Br J Clin Pract; 1995; 49(3):149-51. PubMed ID: 7779667
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Innovations in surgical treatment of refractory ascites].
    Mattioli F; Torre GC
    Minerva Chir; 1982 Oct; 37(20):1699-702. PubMed ID: 7177418
    [No Abstract]   [Full Text] [Related]  

  • 59. Peritoneovenous shunts in patients with intractable ascites: palliation at what price?
    Zervos EE; McCormick J; Goode SE; Rosemurgy AS
    Am Surg; 1997 Feb; 63(2):157-62. PubMed ID: 9012430
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Disseminated intravascular coagulation following peritoneo-venous (LeVeen) shunt.
    Gibson PR; Dudley FJ; Jakobovits AW; Salem HH; McInnes IE
    Aust N Z J Med; 1981 Feb; 11(1):8-12. PubMed ID: 6941784
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.